This article published in Rheumatology and Therapy by Radawski et al. identifies and quantifies the unmet needs perceived by United States patients with Rheumatoid Arthritis (RA) currently taking a disease-modifying antirheumatic drug (DMARD). 258 patients were surveyed and only 26% of patients reported that they were satisfied with their RA treatment. Patients not satisfied with their treatment reported higher rheumatic disease impact and half reported a current flare. There is a need for improved disease management among RA patients.